# Fulvestrant

## Faslodex inj 250mg/5mL

##### 臨採

| 藥品代碼   | IFAS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|:-----------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症     | Breast cancer， metastatic， breast cancer， advanced or metastatic (second-line endocrine-based combination therapy)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 用法用量   | 500 mg administered intramuscularly into the buttocks (gluteal area) slowly (1 -2 minutes per injection) as two 5 mL injections， one in each buttock， on Days 1， 15， 29， and once monthly thereafter.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 肝功能異常 | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 腎功能異常 | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 禁忌       | a) hypersensitivity to fulvestrant or to any of its components b) suspected or known pregnancy Precautions A) hepatic impairment Serious Adverse Effects: a) Anemia b) Angioedema                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 副作用     | >10%: Central nervous system: Fatigue (8% to 29%)， headache (8% to 20%) Gastrointestinal: Nausea (10% to 28%)， diarrhea (19%)， constipation (5% to 16%)， stomatitis (13%) Hematologic & oncologic: Anemia (13% to 40%; grade 3: 2%) Hepatic: Increased liver enzymes (>15%; grades 3/4: 1% to 2%) Infection: Infection (31%; including nasopharyngitis， upper respiratory infection， urinary tract infection， influenza， bronchitis， rhinitis， conjunctivitis， pneumonia， sinusitis， cystitis， oral herpes， respiratory tract infection) Local: Pain at injection site (12%; including neuralgia， peripheral neuropathy， sciatica) 1% to 10%: Dermatologic: Alopecia (6%)， skin rash (6%)， xeroderma (1%) Endocrine & metabolic: Hot flash (7%) Gastrointestinal: Decreased appetite (8%)， anorexia (6%)， vomiting (6%)， dysgeusia (3%) Hematologic & oncologic: Decreased platelet count (10%)， leukopenia (5%; grade 3: 1%; grade 4: 1%)， neutropenia (4%; grade 3: 1%)， febrile neutropenia (1%; grade 4: 1%) Neuromuscular & skeletal: Ostealgia (9%)， arthralgia (8%)， back pain (8%)， limb pain (7%)， musculoskeletal pain (6%)， weakness (5% to 6%) Ophthalmic: Blurred vision (2%)， dry eye syndrome (2%)， increased lacrimation (1%) Respiratory: Cough (5%)， dyspnea (4%)， epistaxis (2%) |
| 孕期建議   | No Data                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 哺乳期建議 | Contraindicated 哺乳期使用禁忌                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |

